Rosetta Omics
Rosetta Omics is dedicated to advancing precision medicine in oncology through tumor characterization using high-resolution mass spectrometry profiling and AI. Their mission is to help oncologists, clinicians, and pathologists better diagnose, stratify, and rank treatment options for cancer patients from a single tissue slide. They utilize innovative technologies such as MSI, LMD, LC-MS/MS, and AI algorithms to identify biomarkers, predict treatment responses, and discover new therapeutic targets, ultimately aiming to improve patient outcomes and support drug development.
Industries
Nr. of Employees
small (1-50)
Rosetta Omics
Products
Patented conductive-slide tissue analysis method
A patented methodology for using conductive microscope slides to study analytes on tissue sections while preserving protein integrity; intended to support spatial omics workflows.
Rosetta Omics Platform
An integrated multi-omics precision oncology platform that combines spatial omics, mass spectrometry, gene expression analysis, and advanced AI algorithms to deliver molecular insights, patient stratification, and treatment response prediction from single tissue biopsies.
Patented conductive-slide tissue analysis method
A patented methodology for using conductive microscope slides to study analytes on tissue sections while preserving protein integrity; intended to support spatial omics workflows.
Rosetta Omics Platform
An integrated multi-omics precision oncology platform that combines spatial omics, mass spectrometry, gene expression analysis, and advanced AI algorithms to deliver molecular insights, patient stratification, and treatment response prediction from single tissue biopsies.
Services
Laboratory service that performs spatial and bulk molecular profiling on biopsy-compatible tissue sections to produce molecular signatures for tumor characterization.
Machine-learning-driven analysis that generates treatment-response predictions and ranks therapeutic options based on a patient’s molecular profile.
Discovery services to identify known and novel biomarkers from multi-omics data to support diagnostic validation and therapeutic development.
Laboratory service that performs spatial and bulk molecular profiling on biopsy-compatible tissue sections to produce molecular signatures for tumor characterization.
Machine-learning-driven analysis that generates treatment-response predictions and ranks therapeutic options based on a patient’s molecular profile.
Discovery services to identify known and novel biomarkers from multi-omics data to support diagnostic validation and therapeutic development.
Expertise Areas
- Spatial proteomics and metabolomics
- Multi-omics tumor profiling
- Biomarker discovery and validation
- Mass spectrometry-based proteomics
Key Technologies
- Mass spectrometry imaging (MALDI-MSI)
- Liquid chromatography–tandem mass spectrometry (LC-MS/MS)
- Laser capture microdissection
- Label-free quantitative proteomics